Matulonis U - Search Results

1

Stereologic analysis of monocytes and their subcellular organelles in patients with acute monocytic and myelomonocytic leukemia.

Weiselberg L, Matulonis U, McGarvey E, Roberts B, Lichtman S, Allen S, Vinciguerra V, Teichberg S. Weiselberg L, et al. Among authors: matulonis u. Lab Invest. 1990 Sep;63(3):405-12. Lab Invest. 1990. PMID: 2395334

2

Reply to Z.R. McCaw et al.

Matulonis UA, Lorusso D, Oaknin A, Pignata S, Dean A, Denys H, Colombo N, Van Gorp T, Konner JA, Marin MR, Harter P, Murphy CG, Wang J, Noble E, Esteves B, Method M, Coleman RL. Matulonis UA, et al. J Clin Oncol. 2023 Oct 10;41(29):4705-4706. doi: 10.1200/JCO.23.00752. Epub 2023 Aug 3. J Clin Oncol. 2023. PMID: 37535884 No abstract available.

3

Factor independence of human myeloid leukemia cell lines is associated with increased phosphorylation of the proto-oncogene Raf-1.

Okuda K, Matulonis U, Salgia R, Kanakura Y, Druker B, Griffin JD. Okuda K, et al. Among authors: matulonis u. Exp Hematol. 1994 Oct;22(11):1111-7. Exp Hematol. 1994. PMID: 7925778

4

Tyrosine phosphorylation of rasGAP and associated proteins in chronic myelogenous leukemia cell lines.

Druker B, Okuda K, Matulonis U, Salgia R, Roberts T, Griffin JD. Druker B, et al. Among authors: matulonis u. Blood. 1992 May 1;79(9):2215-20. Blood. 1992. PMID: 1571536 Free article.

5

Role of B7-1 in mediating an immune response to myeloid leukemia cells.

Matulonis UA, Dosiou C, Lamont C, Freeman GJ, Mauch P, Nadler LM, Griffin JD. Matulonis UA, et al. Blood. 1995 May 1;85(9):2507-15. Blood. 1995. PMID: 7537118 Free article.

6

Autologous peripheral stem cell transplantation of the blastic phase of chronic myeloid leukemia following sequential high-dose cytosine arabinoside and melphalan.

Matulonis UA, Griffin JD, Canellos GP. Matulonis UA, et al. Am J Hematol. 1994 Apr;45(4):283-7. doi: 10.1002/ajh.2830450403. Am J Hematol. 1994. PMID: 7909981 Clinical Trial.

7

Interleukin-3 and p210 BCR/ABL activate both unique and overlapping pathways of signal transduction in a factor-dependent myeloid cell line.

Matulonis U, Salgia R, Okuda K, Druker B, Griffin JD. Matulonis U, et al. Exp Hematol. 1993 Oct;21(11):1460-6. Exp Hematol. 1993. PMID: 8405226

8

Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.

Ni Chonghaile T, Sarosiek KA, Vo TT, Ryan JA, Tammareddi A, Moore Vdel G, Deng J, Anderson KC, Richardson P, Tai YT, Mitsiades CS, Matulonis UA, Drapkin R, Stone R, Deangelo DJ, McConkey DJ, Sallan SE, Silverman L, Hirsch MS, Carrasco DR, Letai A. Ni Chonghaile T, et al. Science. 2011 Nov 25;334(6059):1129-33. doi: 10.1126/science.1206727. Epub 2011 Oct 27. Science. 2011. PMID: 22033517 Free PMC article.

9

Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response.

Zervantonakis IK, Iavarone C, Chen HY, Selfors LM, Palakurthi S, Liu JF, Drapkin R, Matulonis U, Leverson JD, Sampath D, Mills GB, Brugge JS. Zervantonakis IK, et al. Among authors: matulonis u. Nat Commun. 2017 Aug 28;8(1):365. doi: 10.1038/s41467-017-00263-7. Nat Commun. 2017. PMID: 28848242 Free PMC article.

10

Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel.

Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, Duska LR, Fuller AF, Goodman AK, Nikrui N, MacNeill KM, Matulonis UA, Preffer FI, Seiden MV. Penson RT, et al. Among authors: matulonis ua. Int J Gynecol Cancer. 2000 Jan;10(1):33-41. doi: 10.1046/j.1525-1438.2000.00003.x. Int J Gynecol Cancer. 2000. PMID: 11240649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

327 results

Search Page